| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.0032 |
0.9 |